INS and type 2 diabetes mellitus: Regulation of ENaC by phosphoinositides may underlie insulin(INS, P01308)‐evoked renal Na+ retention that can complicate the clinical management of type 2 diabetes using insulin‐sensitizing thiazolidinedione drugs [132].